Hostname: page-component-74656f9884-c52kr Total loading time: 0 Render date: 2026-11-07T00:53:06.963Z Has data issue: false hasContentIssue false
  • English
  • Français

Question-and-Answer Session

Published online by Cambridge University Press:  07 November 2014

Get access Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

1.Fava, M, Rush, AJ, Alpert, JE, et al.Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. Am J Psychiatry. 2008;165(3):342–351.CrossRefGoogle ScholarPubMed
2.Candy, M, Jones, L, Williams, R, Tookman, A, King, M. Psychostimulants for depression. Cochrane Database Syst Rev. 2008;(2):CD006722.Google Scholar
3.Masand, PS, Tesar, GE. Use of stimulants in the medically ill. Psychiatr Clin North Am. 1996;19(3):515–547.Google Scholar
4.Scheffer, RE, Kowatch, RA, Carmody, T, Rush, AJ. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium. Am J Psychiatry. 2005;162(1):58–64.Google Scholar
5.Nierenberg, AA, Miyahara, S, Spencer, T, et al, and the STEP-BD Investigators. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants. Biol Psychiatry. 2005;57(11):1467–1473.CrossRefGoogle ScholarPubMed